Apr 24 |
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
|
Apr 24 |
TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares
|
Apr 22 |
TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
|
Apr 19 |
TScan Therapeutics Announces Closing of Upsized Public Offering
|
Apr 17 |
TScan Therapeutics prices upsized stock offering to raise $150 million
|
Apr 17 |
TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
|
Apr 16 |
TScan Therapeutics announces launch of $125M proposed public offering
|
Apr 16 |
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
|
Apr 16 |
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
|
Apr 8 |
TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer
|